cancer-related death. Also, during the past decade, a trend of increasing incidence of proximal gastric cancer has been reported by a number of investigators [1] [2] [3] [4] . A similar change in the pattern of gastric cancer localization has been observed in Europe and Asia [5] [6] [7] . The cause of this increase in the incidence of proximal gastric cancer is under active investigation.
Proximal gastric cancer has a different clinical and biologic behavior from that of gastric cancer in other locations. Specifically, several investigators have reported a worse prognosis for patients who have proximal gastric cancer than for those whose cancer is located in the mid or distal portion of the stomach [6] [7] [8] [9] . Additionally, the incidence of proximal gastric cancer is higher among non-Hispanic whites [1] , and obesity may play a role in its pathogenesis. For example, in two casecontrol studies conducted in the United States and one conducted in Sweden, an association between a high body mass index and adenocarcinoma of the gastric cardia was observed [4, 10, 11] . Tobacco use has also been reported to increase the risk of proximal gastric cancer [7, 10, 12, 13] .
Sex may also play a role in the biology of gastric cancer. In a Korean study involving 10 783 patients who had undergone gastric resection, women had a slight but statistically significantly superior 5-year survival rate when compared with men (57.8% vs 54.6%; P ϭ 0.0175) [6] . This finding was confirmed in an analysis of the National Cancer Data Base [9] . In this joint report by the American College of Surgeons and American Cancer Society, Hundahl and colleagues found that women had superior 5-year (31% vs 25%) and 10-year survival rates (24% vs 18%) when compared with men.
In the present study, we evaluated the effects of the patient's ethnicity and sex on the location of gastric cancer in patients seen at The University of Texas M. D. Anderson Cancer Center. The effects of gastric cancer localization on symptoms at the time of diagnosis were also examined.
Introduction
In the United States, the overall incidence of gastric cancer has been on the decline since 1930. However, gastric cancer remains one of the top ten causes of
Patients and methods

Patient population
The present study included all gastric cancer patients who registered at M. D. Anderson Cancer Center from January 1, 1985, to May 31, 1998. Each patient's medical record was analyzed. The diagnosis of gastric adenocarcinoma was confirmed, and the tumor location was identified.
Classification and data collection
Cancer location was established using esophagogastroduodenoscopy or an upper gastrointestinal X-ray series, or at surgery. Cancers centered at the esophagogastric junction, gastric cardia, or gastric fundus were classified as proximal, while those centered in the rest of the stomach were classified as nonproximal. Diffuse involvement of the stomach was also classified as nonproximal.
Similar to the classification system used by the Surveillance, Epidemiology, and End Results (SEER) program [14] , we divided the patients into five racial/ ethnic groups, non-Hispanic white, Hispanic, African American, Asian, and Native American.
The patients' symptoms at the time of diagnosis were obtained from their records. Weight loss was defined as the loss of more than 10% of body weight or 10 pounds (4.54 kg); a description of significant weight loss was also accepted if weight measurements were not available. A database was established, and an oncologist verified all data in the database.
Statistical analysis
The 2 test was used to test factors that were associated with gastric cancer localization. The univariate odds ratio (OR) was computed for proximal versus nonproximal gastric cancer location. Additionally, multivariate logistic regression analyses were performed to provide multivariate ORs for factors affecting gastric cancer localization and to adjust for the effect of study factors. Finally, two-sided P values were reported.
Results
Patient characteristics
The case records of 1339 consecutive patients who had gastric cancer were examined. This analysis included only 1242 patients (93%). The reasons for ineligibility in the remaining cases included a lack of proximal to distal location information (69 cases), gastric remnant cancer (23 cases; not classifiable in the proximal to distal orientation), and a lack of racial and ethnicity information (5 cases).
Of the patients included, 783 (63%) were men, and 459 (37%) were women. This is similar to the distribution observed during the same period in the SEER database. The distribution of cancer is illustrated in Fig.  1 . A description of the patient characteristics by sex is outlined in Table 1 . The median duration from the date of tissue diagnosis to first visit at M. D. Anderson Cancer Center was 18 days.
Symptoms present at time of gastric cancer diagnosis
Abdominal pain and weight loss were the two most common symptoms present at the time of diagnosis. These occurred in 58% and 40% of the patients, respectively. When the symptoms were analyzed according to the location of the cancer within the stomach, the types experienced by the patients were related to the location (Table 2) . Specifically, dysphagia occurred predominantly in patients with proximal gastric cancer, while abdominal pain, nausea/vomiting, and early sati- ety were associated with nonproximal gastric cancer. Weight loss and bleeding occurred with similar frequency among proximal and nonproximal gastric cancer patients.
Gastric cancer location
As there were only three Native Americans present, they were excluded from comparative analyses. Univariate analyses showed that proximal cancer localization was more common among non-Hispanic whites and men. Proximal gastric cancer localization was observed in 50% of non-Hispanic white patients compared with 25%, 36%, and 35% of Asian, African American, and Hispanic patients (P Ͻ 0.001). Proximal gastric cancer localization was observed in 50% of male patients compared with 35% of female patients (P Ͻ 0.001). Age at time of diagnosis was similar between patients with proximal and nonproximal gastric cancer (mean ages of 58 years and 57 years, respectively). When analyzed as a continuous variable by logistic regression, age at time of cancer diagnosis did not affect cancer localization (P ϭ 0.21).
Next, we examined the effect of racial/ethnic group on gastric cancer localization among men and women as separate groups. Among the 459 women, racial/ethnic group did not have a significant impact on the frequency of proximal gastric cancer localization. Among the 783 men, proximal cancer localization was significantly more frequent in the non-Hispanic white group (P Ͻ 0.0001). The effects of racial/ethnic group on gastric cancer localization were thus dependent on patient sex (Table 3) .
We also performed logistic regression analyses to adjust for the effects of study factors and to formally analyze the interaction between sex and racial/ethnic group (Table 4) . In multivariate analyses, sex and racial/ethnic group independently affected gastric cancer localization. Men were more likely to have proximal gastric cancer than women (P Ͻ 0.001). Non-Hispanic white patients were more likely to have proximal gastric cancer localization than Hispanic, African American, and Asian patients (P Ͻ 0.001).
When the interaction of racial/ethnic group by sex was added to the model, the effect of racial/ethnic group was dependent on sex (P ϭ 0.021). Proximal gastric cancer localization was more frequent among nonHispanic white men. Non-Hispanic white women had a pattern of gastric cancer localization similar to those of the other racial/ethnic groups.
Discussion
The rising incidence of proximal gastric cancer has wide-reaching clinical implications. Proximal tumors [1, 6, 9] . In our study, proximal localization was strikingly more frequent in non-Hispanic white men, while nonHispanic white women had a pattern of gastric cancer localization similar to those of other ethnic-racial groups. Given the poorer prognosis of proximal gastric cancer, the higher proportion of proximal tumors observed in non-Hispanic white men in our study may contribute to the small but consistent survival advantage in women reported by Kim et al. [6] and Hundahl et al. [9] . Our study was conducted at the M. D. Anderson Cancer Center, a major cancer referral center that is thus potentially subject to referral bias. However, several facts make this bias unlikely in the present study. First, the proportion of male to female patients having gastric cancer was similar to the national average [15] . Second, if proximal gastric cancer is defined as cancer of the esophagogastric junction, gastric cardia, or gastric fundus, then the proportion of patients having proximal gastric cancer in the present study is similar to that in other large population-based studies. In the recent report of the National Cancer Data Base by Hundahl et al. [9] , 31% of the patients had cancer of the gastric cardia or fundus, and 38% of patients did not have their cancers classified in the proximal to distal orientation. Thus, of the patients having gastric cancer classified in this orientation, approximately 50% had localization in the gastric cardia or fundus. This percentage is similar to the 45% observed in our study.
Our present study is unique in an important aspect. Previous reports of the clinical behavior of proximal gastric cancer were limited to patients undergoing surgery. However, differing rates of advanced unresectable disease among patients with proximal and nonproximal gastric cancer may bias such studies. In the present study, we included all patients regardless of resectability.
The type of surgical resection used is an area of controversy in the treatment of proximal gastric cancer. Some investigators have advocated the use of total gastrectomy with extensive (D2 or higher) lymphadenectomy for proximal gastric cancer. However, two prospective randomized trials comparing D1 versus D2 lymphadenectomy for gastric cancer, conducted in the Netherlands [16] and England [17] , reported much higher rates of operative complications in the D2 group. Further, no improvements in the 5-year survival rates were observed for the D2 group. In the United States, D2 or higher lymphadenectomy is rarely performed [18] . Also, in a recent analysis of 110 cases of proximal gastric cancer, Shimada et al. [19] found that Japanese patients undergoing D2 dissection with total gastrectomy had higher morbidity and mortality rates when compared with patients undergoing D1 dissection with proximal gastrectomy. The investigators recommended D1 dissection with proximal gastrectomy for patients who have a superficial tumor less than 4 cm in size.
In addition, quality of life after gastrectomy differs depending on the type of gastrectomy performed. In a study of Japanese patients who underwent gastric resection with D2 lymphadenectomy, Korenaga et al. [20] showed that patients had inferior food tolerance, weight, and performance status compared with those who underwent partial gastrectomy. Also, in a British study, Anderson and MacIntyre [21] found that new symptoms (those not present prior to surgical resection) were more frequent after total gastrectomy than after partial gastrectomy or esophagectomy with proximal partial gastrectomy.
The findings described above suggest that proximal gastrectomy may be adequate for T1 or T2 proximal gastric carcinoma, resulting in fewer postoperative complications. Newer treatment strategies, such as preoperative chemotherapy or postoperative chemoradiotherapy, as carried out in the Intergroup 0116 trial, may improve outcomes in patients having proximal gastric cancer [22] . In conclusion, proximal gastric cancer has different symptoms and types of clinical behavior and may have different risk factors from nonproximal gastric cancer. Current staging systems and treatment strategies do not fully exploit these differences. Further investigations are needed to delineate the clinical and molecular differences between patients with proximal and nonproximal gastric cancer.
